Cited by 36Malaria Research and ControlGlobal Maternal and Child HealthHemoglobinopathies and Related Disorders

Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania

Open access
Mikomangwa, Wigilya P., Minzi, Omary, Mutagonda, Ritah, Baraka, Vito, Mlugu, Eulambius M., Aklillu, Eleni, Kamuhabwa, Appolinary A. R.·2020·Malaria Journal

Published version of a preprint

Abstract

BACKGROUND: Malaria in pregnancy increases the risk of deleterious maternal and birth outcomes. The use of ≥ 3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (IPTp-SP) is recommended for preventing the consequences of malaria during pregnancy. This study assessed the effect of IPTp-SP for prevention of malaria during pregnancy in low transmission settings. METHODS: A cross-sectional study that involved consecutively selected 1161 pregnant women was conducted at Mwananyamala regional referral hospital in Dar es Salaam. Assessment of the uptake of IPTp-SP was done by extracting information from antenatal clinic cards. Maternal venous blood, cord blood, placental blood and placental biopsy were collected for assessment of anaemia and malaria. High performance liquid chromatography with ultraviolet detection (HPLC-UV) was used to detect and quantify sulfadoxine (SDX). Dried blood spots (DBS) of placental blood were collected for determination of sub-microscopic malaria using polymerase chain reaction (PCR). RESULTS: In total, 397 (34.2%) pregnant women reported to have used sub-optimal doses (≤ 2) while 764 (65.8%) used optimal doses (≥ 3) of IPTp-SP at the time of delivery. The prevalence of placental malaria as determined by histology was 3.6%. Submicroscopic placental malaria was detected in 1.4% of the study participants. Women with peripheral malaria had six times risk of maternal anaemia than those who were malaria negative (aOR, 5.83; 95% CI 1.10-30.92; p = 0.04). The geometric mean plasma SDX concentration was 10.76 ± 2.51 μg/mL. Sub-optimal IPTp-SP dose was not associated with placental malaria, premature delivery and fetal anaemia. The use of ≤ 2 doses of IPTp-SP increased the risk of maternal anaemia by 1.36-fold compared to ≥ 3 doses (aOR, 1.36; 95% CI 1.04-1.79; p = 0.02). CONCLUSION: The use of < 2 doses of IPTp-SP increased the risk of maternal anaemia. However, sub-optimal doses (≤ 2 doses) were not associated with increased the risk of malaria parasitaemia, fetal anaemia and preterm delivery among pregnant women in low malaria transmission setting. The use of optimal doses (≥ 3 doses) of IPTp-SP and complementary interventions should continue even in areas with low malaria transmission.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12936-020-03234-4

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [42]Iván B Anemia of infection. Iron metabolism 1983 Boston Springer 275 283

Cited by

Sorted by citations

Authors
Mikomangwa, W. P., Minzi, O., Mutagonda, R., Baraka, V., Mlugu, E. M., Aklillu, E., & Kamuhabwa, A. A. R.
Affiliations
  • Muhimbili University of Health and Allied Sciences (TZ)
  • National Institute for Medical Research (TZ)
  • Karolinska University Hospital (SE)
Corresponding author
Mikomangwa, Wigilya P.
Venue
Malaria Journal
Published
2020-04-19
Volume
19
Issue
1
Pages
160-160
ISSN
1475-2875 (ISSN-L)
OpenAlex
W3016416111
Cited by
36
References
45
Citations by year
2026: 3 · 2025: 10 · 2024: 9 · 2023: 6 · 2022: 6 · 2021: 2
FWCI
2.62
Type
journal article
Language
en
Open access
Locations
  • Malaria Journal (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Styrelsen för Internationellt Utvecklingssamarbete
  • Muhimbili University of Health and Allied Sciences
  • University of Health and Allied Sciences
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
  • Health Sciences › Medicine › Genetics › Hemoglobinopathies and Related Disorders
Keywords
sulfadoxine-pyrimethamine, intermittent preventive treatment in pregnancy, malaria in pregnancy, anemia in pregnancy, placental malaria, submicroscopic malaria infection, low transmission settings, Tanzania, Dar es Salaam, placental histology, fetal anemia, preterm birth, placental biopsy, dried blood spots
MeSH terms
Adult, Antimalarials, Cross-Sectional Studies, Drug Combinations, Female, Humans, Malaria, Pregnancy, Pyrimethamine, Sulfadoxine, Tanzania, Pregnancy Complications, Parasitic, Endemic Diseases, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review